JPWO2023145831A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023145831A5 JPWO2023145831A5 JP2023576985A JP2023576985A JPWO2023145831A5 JP WO2023145831 A5 JPWO2023145831 A5 JP WO2023145831A5 JP 2023576985 A JP2023576985 A JP 2023576985A JP 2023576985 A JP2023576985 A JP 2023576985A JP WO2023145831 A5 JPWO2023145831 A5 JP WO2023145831A5
- Authority
- JP
- Japan
- Prior art keywords
- statin
- pharmaceutical composition
- loaded nanoparticles
- composition according
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022012146 | 2022-01-28 | ||
| PCT/JP2023/002470 WO2023145831A1 (ja) | 2022-01-28 | 2023-01-26 | 網膜色素変性症を治療するための医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023145831A1 JPWO2023145831A1 (https=) | 2023-08-03 |
| JPWO2023145831A5 true JPWO2023145831A5 (https=) | 2025-07-10 |
Family
ID=87471563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023576985A Pending JPWO2023145831A1 (https=) | 2022-01-28 | 2023-01-26 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250144041A1 (https=) |
| EP (1) | EP4470531A4 (https=) |
| JP (1) | JPWO2023145831A1 (https=) |
| CN (1) | CN119031907A (https=) |
| WO (1) | WO2023145831A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004149480A (ja) * | 2002-10-31 | 2004-05-27 | Saisentan Igaku Kenkyusho:Kk | 経口又は経皮投与用の眼科疾患治療剤 |
| WO2004103960A2 (en) * | 2003-05-16 | 2004-12-02 | Ambit Biosciences Corporation | Compounds and uses thereof |
| US10568860B2 (en) * | 2006-08-30 | 2020-02-25 | Kowa Co., Ltd. | Pharmaceutical composition containing statin-encapsulated nanoparticle |
| WO2008044339A1 (en) * | 2006-10-13 | 2008-04-17 | Aqumen Biopharmaceuticals K.K. | Therapeutic/preventive agent for intraocular disease containing statin compound |
| CN101959542B (zh) * | 2007-12-25 | 2014-11-12 | 国立大学法人山口大学 | 药物传递系统 |
| JP2023517582A (ja) * | 2020-03-11 | 2023-04-26 | ウニヴェルジテート レーゲンスブルク | 眼疾患の処置における使用のためのナノ粒子 |
| JP6978016B1 (ja) | 2020-07-01 | 2021-12-08 | 株式会社システムフォワード | 来場者管理システム及び来場者管理方法 |
-
2023
- 2023-01-26 JP JP2023576985A patent/JPWO2023145831A1/ja active Pending
- 2023-01-26 WO PCT/JP2023/002470 patent/WO2023145831A1/ja not_active Ceased
- 2023-01-26 EP EP23747041.4A patent/EP4470531A4/en active Pending
- 2023-01-26 US US18/832,713 patent/US20250144041A1/en active Pending
- 2023-01-26 CN CN202380030920.5A patent/CN119031907A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017119222A (ru) | Нейро-аттенуирующие кетаминовые и норкетаминовые соединения, их производные и способы их получения | |
| JP2011068653A5 (https=) | ||
| CN102497864B (zh) | 用于预防或治疗由化疗诱发的疼痛的σ配体 | |
| JP5911929B2 (ja) | 特定の癌の治療のためのrdea119/bay869766を含む組み合わせ医薬 | |
| JP2017537985A5 (https=) | ||
| RS52274B2 (sr) | Jedinjenje diarilhidantoina | |
| JP2021505575A5 (https=) | ||
| JP2020505423A5 (https=) | ||
| JP2021530541A5 (https=) | ||
| JP2018534254A5 (https=) | ||
| JP2015510916A5 (https=) | ||
| AU2009215329B2 (en) | Combination comprising paclitaxel for treating ovarian cancer | |
| JP2019534330A5 (https=) | ||
| CN105879031A (zh) | 协同治疗肿瘤的非抗癌药组合物 | |
| JPWO2023145831A5 (https=) | ||
| IL300144A (en) | Benzazepines are combined for the treatment of Tourette syndrome | |
| JP2023109829A5 (https=) | ||
| JP2008533021A5 (https=) | ||
| MX2021008208A (es) | Tesofensina para la reduccion del peso corporal para pacientes con sindrome de prader-willi. | |
| JP2018505901A5 (https=) | ||
| JP2016539149A5 (https=) | ||
| FI3650024T3 (fi) | Rifampisiineja sisältävä nenään annettava farmaseuttinen koostumus dementian hoitamiseksi | |
| JP2007534731A5 (https=) | ||
| US20150110864A1 (en) | Novel antitumor agent comprising combination of three agents | |
| JP2020503318A5 (https=) |